Radical Resection
Showing 1 - 25 of 7,060
Gallstone, Gastric Cancer Trial in Lanzhou, Wuwei (Distal gastrectomy and radical resection, Total gastrectomy and radical
Not yet recruiting
- Gallstone
- Gastric Cancer
- Distal gastrectomy and radical resection
- Total gastrectomy and radical resection
-
Lanzhou, Gansu, China
- +1 more
Jul 27, 2023
Hepatocellular Carcinoma Trial in Beijing (1mg NWRD06 administered by electroporation, 4mg NWRD06 administered by
Recruiting
- Hepatocellular Carcinoma
- 1mg NWRD06 administered by electroporation
- +2 more
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Oct 15, 2023
Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)
Not yet recruiting
- Gastric
- Colorectal Adenocarcinoma
-
Shenyang, Liaoning, ChinaLiaoning Cancer Hospital & Institute
Nov 1, 2023
Multivisceral Radical Resection for Surgical T4b Colorectal
Completed
- Colorectal Cancer
- Laparoscopic surgery
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Jan 21, 2023
Incidental Gallbladder Carcinoma, Biliary Tract Cancer Trial in Frankfurt (Gemcitabine, Cisplatin, Oncologically radical
Recruiting
- Incidental Gallbladder Carcinoma
- Biliary Tract Cancer
- Gemcitabine
- +3 more
-
Frankfurt, GermanyKrankenhaus Nordwest gGmbH
Sep 7, 2022
Tubeless NOSES, Traditional Laparoscopic Radical Resection, Rectosigmoid Cancers Trial in GuangZhou (Tubeless NOSES, traditional
Recruiting
- Tubeless NOSES
- +2 more
- Tubeless NOSES
- traditional laparoscopic radical resection
-
GuangZhou, Guangdong, ChinaThe Sixth Affiliate Hospital of Sun Yat-Sen University
Mar 30, 2022
Pancreatic Cancer After Radical Resection
Completed
- Pancreatic Cancer
- preoperative demographics, blood markers, surgical pathology information,and enhanced CT features.
-
Hangzhou, Zhejiang, ChinaZhejiang Province Cancer Hospital
Oct 19, 2022
Retroperitoneal Sarcoma Trial in Singapore (Doxorubicin)
Recruiting
- Retroperitoneal Sarcoma
-
Singapore, SingaporeNational Cancer Centre Singapore
Jun 10, 2022
Musculoskeletal Cancer, Sarcoma,Soft Tissue Trial in Kansas City (Tranexamic Acid (TXA))
Recruiting
- Musculoskeletal Cancer
- Sarcoma,Soft Tissue
- Tranexamic Acid (TXA)
-
Kansas City, KansasUniversity of Kansas Medical Center
May 23, 2022
Colorectal Tumors, Lidocaine Trial in Nantong (Administer 1.5 mg/kg intravenously to the patient before induction of anesthesia,
Recruiting
- Colorectal Tumors
- Lidocaine
- Administer 1.5 mg/kg intravenously to the patient before induction of anesthesia, and continue to infuse 1.5 mg/kg/h during the operation until the end of the operation
-
Nantong, Jiangsu, ChinaAffiliated Hospital of Nantong University
Jul 31, 2022
Hepatocellular Carcinoma Trial in Beijing (Autologous memory lymphocyte Injection (NewishT), low-dose group, Autologous memory
Recruiting
- Hepatocellular Carcinoma
- Autologous memory lymphocyte Injection (NewishT), low-dose group
- Autologous memory lymphocyte Injection (NewishT), high-dose group
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
May 30, 2022
Postoperative Complications, Proteinosis Trial in Chongqing, Yuzhong (Preserve the left colonic artery, The left colonic artery
Completed
- Postoperative Complications
- Proteinosis
- Preserve the left colonic artery
- The left colonic artery is not preserved
-
Chongqing, Chongqing, China
- +1 more
Apr 28, 2022
Hepatocellular Carcinoma Trial in Guangzhou (Ronvatinib + sindillimab, radiofrequency ablation)
Not yet recruiting
- Hepatocellular Carcinoma
- Ronvatinib + sindillimab
- radiofrequency ablation
-
Guangzhou, Guangdong, ChinaThird Affiliated Hospital, Sun Yat-Sen University
Apr 5, 2023
Resection Margin of Transverse Colon Cancer With Extracorporeal
Recruiting
- Transverse Colon Cancer
- approach of anastomosis
-
Shanghai, ChinaShanghai Minimally Invasive Surgery Center
Aug 9, 2022
Department of Anorectal Surgery, Changhai Hospital Affiliated to Naval Medical University Trial (Laparoscopic radical resection
Not yet recruiting
- Department of Anorectal Surgery, Changhai Hospital Affiliated to Naval Medical University
- Laparoscopic radical resection of low rectal cancer with transanal specimens
- (no location specified)
Aug 14, 2022
Prostate Cancer Trial in Basel (3D model guided secondary resection)
Completed
- Prostate Cancer
- 3D model guided secondary resection
-
Basel, SwitzerlandUniversitätsspital Basel Urologie
Jul 17, 2023
Chemo Effect, Rectal Cancer Trial in Guangzhou (Radical total mesorectal excision, Salavge Adjuvant Chemoradiotherapy)
Recruiting
- Chemotherapy Effect
- Rectal Cancer
- Radical total mesorectal excision
- Salavge Adjuvant Chemoradiotherapy
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Sep 12, 2023
Gastric Cancer Trial in Yixing (tirelizumab, chemo with oxaliplatin + heroda)
Recruiting
- Gastric Cancer
- tirelizumab
- chemotherapy with oxaliplatin + heroda
-
Yixing, Jiangsu, ChinaYixing People's Hospital
May 3, 2023
Hepatocellular Carcinoma (HCC) Trial in Beijing (Expanded Activated Lymphocytes (EAL), transarterial chemoembolization (TACE))
Recruiting
- Hepatocellular Carcinoma (HCC)
- Expanded Activated Lymphocytes (EAL)
- transarterial chemoembolization (TACE)
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Feb 4, 2022
Cancer Colorectal Trial (a multi-locus blood-based assay)
Not yet recruiting
- Cancer Colorectal
- a multi-locus blood-based assay
- (no location specified)
Sep 7, 2022
Breast Cancer, Breast Cancer Invasive Trial in Groningen (Fluorescence guided detection of tumor positive margins.)
Not yet recruiting
- Breast Cancer
- Breast Cancer Invasive
- Fluorescence guided detection of tumor positive margins.
-
Groningen, Netherlands
- +1 more
Jul 10, 2023
Antiviral Therapy for Patients With Liver Cancer After Surgery
Recruiting
- Hepatocellular Carcinoma
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Jul 19, 2022
Craniopharyngioma Trial in Jacksonville, Memphis (procedure, device, drug)
Active, not recruiting
- Craniopharyngioma
- Radical Surgery or Limited Surgery
- +3 more
-
Jacksonville, Florida
- +1 more
Jan 5, 2022
Cholangiocarcinoma Trial in Beijing (autologous Tcm cellular immunotherapy)
Recruiting
- Cholangiocarcinoma
- autologous Tcm cellular immunotherapy
-
Beijing, ChinaPeking Union Medical College Hospital
Apr 24, 2022